Skip to content
Spend $300 or more and get 10% off automatically at checkout.
Retatrutide research vial

Metabolic

Retatrutide

LY3437943

Prices in AUD per vial. Check the selected option; product imagery is illustrative.

Selected vial size
10mg
Price per vial
$119.00 AUD
Payment
PayID or bank transfer

Free Australian delivery over $250 before discounts; otherwise $12. Express Post dispatch within 1 business day of cleared payment; most metro addresses 1–2 business days after dispatch. Larger sizes are enquiry-only.

Retatrutide is a synthetic, lipid-conjugated peptide studied as a unimolecular GIP, GLP-1, and glucagon receptor triple agonist in metabolic and energy-homeostasis research models. Each vial is supplied from Australian stock strictly for in-vitro laboratory research use.

Retatrutide specifications

Other names
LY3437943
Sequence
39-amino-acid peptide with a C20 fatty-diacid side chain on lysine (lipidated)
Length
39 amino acids
Molecular formula
C221H342N46O68
Molecular weight
4731.3 g/mol
CAS No.
2381089-83-2
Form
Lyophilized Powder
Vial size
10mg

Sequence, formula and molecular weight are compound reference data, not batch test results.

Store lyophilized powder at -20°C. Reconstituted solution stable at 2-8°C for up to 4 weeks.
1

Retatrutide price in Australia

$119.00 per 10mg lyophilised powder vial · $11.90 per mg

  • 10% off automatically on orders of $300 or more
  • 5% off your first order when you join our email list at checkout
  • Free Express Post on orders over $250
  • Dispatched from Brisbane within one business day of payment
See the full Australian price list

Buying Retatrutide in Australia

Where can I buy Retatrutide in Australia?
You can buy Retatrutide 10mg online from Nautic Peptides, an Australian supplier based in Brisbane (Nautic Peptides Pty Ltd, ABN 60 702 527 679). All stock is held in Australia and every order is sent from Brisbane by tracked Express Post.
Can I buy Retatrutide online in Australia?
Yes. Retatrutide is for sale online at nauticpeptides.com. Add it to your cart, check out in a few steps and pay by PayID or bank transfer, and your order ships once payment is confirmed, typically within 1 business day.
How much is Retatrutide in Australia?
Retatrutide 10mg is $119.00 per vial ($11.90 per mg) at Nautic Peptides. Orders of $300 or more get 10% off automatically, and delivery is free on orders over $250. A larger 20mg size is available on request.
Is Retatrutide available in Australia?
Yes. Retatrutide 10mg is available now, in stock in Queensland and ready to dispatch.
How fast will my Retatrutide order arrive?
Orders are dispatched within one business day of payment by tracked Express Post. Australia Post's typical Express Post timeframe between metro areas is 1–2 business days, and you'll receive tracking as soon as your order ships.
How do I pay for Retatrutide?
Pay securely by PayID or direct bank transfer. PayID usually arrives within minutes, and your order ships as soon as payment clears.

Often viewed with Retatrutide

Supplier certificate of analysis

Batch no.
RET-26031501
Report date
15 Mar 2026
Purity (HPLC), supplier-reported
99.2%
Mass spectrum
4731.1 (expected 4731.4 ± 1.0)

Our current stock of this product was produced from this batch. This is the manufacturer's certificate of analysis for that production batch.

  • Registered Australian company

    Nautic Peptides Pty Ltd, ABN 60 702 527 679

    Check on ABN Lookup
  • Dispatched from Queensland

    Within 1 business day of cleared payment, with tracking

    Dispatch policy
  • Secure, discreet packaging

    Packed securely and discreetly for dispatch

    Research standards
  • Damaged or incorrect items

    Contact us with photos and we'll sort out a remedy

    Refunds policy

For in-vitro laboratory research only. Not for human or veterinary use.

In the research literature

Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist. A Phase 2 randomized, placebo-controlled trial published in NEJM reported significant body-weight reductions in adults with obesity, and a completed Phase 3 trial (TRANSCEND-T2D-1) reported efficacy and safety data in type 2 diabetes. This is one of the few compounds in this catalog with completed human Phase 3 data, though it remains investigational and is not TGA-approved for any use.

Cited studies describe published research findings, primarily from preclinical or early-phase models. This is not a claim of safety or effectiveness for human use.

Retatrutide research and related reading

Often researched alongside: MOTS-c 10mg

Browse all Nautic research guides